Joan Merrill to Tumor Necrosis Factor Ligand Superfamily Member 13
This is a "connection" page, showing publications Joan Merrill has written about Tumor Necrosis Factor Ligand Superfamily Member 13.
Connection Strength
1.345
-
Commentary: Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders. Front Immunol. 2020; 11:592639.
Score: 0.737
-
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus: Results of a Twenty-Four-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase IIb Study. Arthritis Rheumatol. 2018 02; 70(2):266-276.
Score: 0.608